Stockscreener 앱 받기
172.38
1.53%
-2.68
시장 영업 전:
172.38
Iqvia Holdings Inc 주식(IQV)의 최신 뉴스
Why (IQV) Price Action Is Critical for Tactical Trading - Stock Traders Daily
IQVIA expands collaboration with Kexing Biopharm on biosimilars - Investing.com
IQVIA Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
IQVIA expands collaboration with Kexing Biopharm on biosimilars By Investing.com - Investing.com Canada
AI-powered trials to speed global biosimilar drugs in IQVIA-Kexing pact - Stock Titan
IQVIA Holdings stock (US46266C1053): Global leader in healthcare data analytics - AD HOC NEWS
IQVIA Q1 2026 slides: earnings beat drives guidance raise By Investing.com - Investing.com Canada
IQVIA Q1 2026 slides: earnings beat drives guidance raise - Investing.com
Earnings call transcript: IQVIA surpasses Q1 2026 forecasts, stock surges - Investing.com
Earnings call transcript: IQVIA surpasses Q1 2026 forecasts, stock surges By Investing.com - Investing.com Australia
IQVIA’s Q1 Earnings Call: Our Top 5 Analyst Questions - Barchart.com
IQVIA Holdings Inc. stock outperforms competitors on strong trading day - MSN
IQVIA (NYSE: IQV) director granted 171 deferred shares at $178.64 - Stock Titan
IQVIA (NYSE: IQV) director Colleen Goggins receives 214 Deferred Shares grant - Stock Titan
IQVIA (NYSE: IQV) director Jim Fasano receives 228 deferred share award - Stock Titan
IQVIA (NYSE: IQV) director awarded 185 deferred shares with 1:1 common conversion - Stock Titan
IQVIA Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch
Why is Larry Robbins Bullish on IQVIA Holdings (IQV) Amid Market Volatility - Kavout
IQVIA Holdings Inc. (IQV): Larry Robbins Is Bullish on This Stock - Insider Monkey
Why IQVIA Holdings (IQV) Is Up 12.8% After Q1 Beat and Bigger Buyback Plan – And What's Next - Sahm
Dark Horse Consulting Group and KunTuo Announce Memorandum of Understanding Providing Cell and Gene Therapy Developers with an Accelerated Path to Clinical Development in China - GlobeNewswire Inc.
IQVIA Holdings, Inc. (IQV) Stock Analysis: Robust Growth Potential With A 27.92% Upside - DirectorsTalk Interviews
IQVIA Holdings earnings preview: What to expect - MSN
IQVIA Q1 Earnings Call Highlights - sharewise.com
Here's why you should retain IQV stock in your portfolio now - MSN
IQVIA Holdings stock (US46266C1053): Data?driven healthcare analytics in focus for US investors - AD HOC NEWS
IQVIA board authorizes additional $2B in share repurchases - MSN
IQVIA Expands Share Repurchase Authorization by $2 Billion - The Globe and Mail
BMO Capital Maintains IQVIA Holdings(IQV.US) With Buy Rating, Maintains Target Price $210 - Moomoo
IQVIA Holdings Inc. (NYSE:IQV) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year - simplywall.st
IQVIA Holdings | 8-K: Current report - Moomoo
Earnings Update: IQVIA Holdings Inc. (NYSE:IQV) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts - Yahoo Finance
IQVIA Increases Share Repurchase Authorization by $2 Billion, Bringing Total to $3.2 Billion 1 - Minichart
Artificial Intelligence in Epidemiology Market Is Going - openPR.com
IQVIA Board of Directors Approves $2 Billion Increase in Share Repurchase Authorization - The National Law Review
IQVIA Board Approves $2B Increase to Share Repurchase Authorization, $3.2B Remaining - TradingView
IQVIA board authorizes additional $2 billion stock buyback - Investing.com
IQVIA board authorizes additional $2 billion stock buyback By Investing.com - Investing.com Australia
IQVIA (NYSE: IQV) boosts buyback plan, $3.2B now authorized - Stock Titan
IQVIA Holdings (IQV) Q1 earnings and revenues beat estimates - MSN
Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), Contineum Therapeutics, Inc. Class A (CTNM) and Exelixis (EXEL) - The Globe and Mail
Barclays Sticks to Their Buy Rating for IQVIA Holdings (IQV) - The Globe and Mail
IQVIA Holdings (IQV) Earnings Growth And 8.3% Margin Keep Backlog Narrative In Question - Sahm
IQVIA CFO to Speak at Bank of America Health Care Conference 2026 - BioSpace
IQVIA Holdings Hits Day High with 9.62% Surge in Stock Price - Markets Mojo
Citigroup Maintains IQVIA Holdings (IQV) Neutral Recommendation - MSN
IQVIA Holdings | 8-K: IQVIA Reports First-Quarter 2026 Results - Moomoo
IQVIA Holdings Inc. announces an Increase in Equity Buyback. - marketscreener.com
4.35%
0.35%
자본화:
|
볼륨(24시간):